After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. The stock was recently discussed on Yahoo Finance as it revealed that Replimune Announces Appointment of Sushil Patel to CEO and Executive Leadership Transitions.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Replimune Group Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Replimune Group Inc is $506.47M. A total of 0.99 million shares were traded on the day, compared to an average of 1.47M shares.
In the most recent transaction, Xynos Konstantinos sold 7,313 shares of REPL for 10.92 per share on Nov 16 ’23. After the transaction, the Chief Medical Officer now owns 112,714 company shares. In a previous transaction on Nov 16 ’23, Sarchi Christopher sold 5,255 shares at 10.92 per share. REPL shares that Chief Commercial Officer owns now total 72,245.
Among the insiders who sold shares, Esposito Pamela disposed of 300 shares on Sep 12 ’23 at a per-share price of $20.00. This resulted in the Chief Business Officer holding 263,436 shares of REPL after the transaction. In another insider transaction, Esposito Pamela sold 5,358 shares at $20.01 per share on Sep 11 ’23. Company shares held by the Chief Business Officer now total 263,436.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, REPL has a high of $24.81 and a low of $5.89.
As of this writing, REPL has an earnings estimate of -$0.79 per share for the current quarter. EPS was calculated based on a consensus of 8 estimates, with a high estimate of -$0.7 per share and a lower estimate of -$0.86. The company reported an EPS of -$0.9 in the last quarter, which was -4.70% lower than expectations of -$0.86.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. REPL’s latest balance sheet shows that the firm has $395.65M in Cash & Short Term Investments as of fiscal 2022. There were $32.84M in debt and $20.76M in liabilities at the time. Its Book Value Per Share was $6.87, while its Total Shareholder’s Equity was $411.23M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for REPL is Buy with a score of 5.00.
